[go: up one dir, main page]

PT2382198E - Processos e intermediários para a preparação de um inibidor macrocíclico de protease do vhc - Google Patents

Processos e intermediários para a preparação de um inibidor macrocíclico de protease do vhc

Info

Publication number
PT2382198E
PT2382198E PT09801447T PT09801447T PT2382198E PT 2382198 E PT2382198 E PT 2382198E PT 09801447 T PT09801447 T PT 09801447T PT 09801447 T PT09801447 T PT 09801447T PT 2382198 E PT2382198 E PT 2382198E
Authority
PT
Portugal
Prior art keywords
intermediates
preparing
processes
hcv
protease inhibitor
Prior art date
Application number
PT09801447T
Other languages
English (en)
Inventor
Dominique Paul Michel Depre
Dominic John Ormerod
Andras Horvath
Veronique Cerpentier
Original Assignee
Janssen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceuticals Inc filed Critical Janssen Pharmaceuticals Inc
Publication of PT2382198E publication Critical patent/PT2382198E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/475Preparation of carboxylic acid esters by splitting of carbon-to-carbon bonds and redistribution, e.g. disproportionation or migration of groups between different molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT09801447T 2008-12-23 2009-12-22 Processos e intermediários para a preparação de um inibidor macrocíclico de protease do vhc PT2382198E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08172691 2008-12-23

Publications (1)

Publication Number Publication Date
PT2382198E true PT2382198E (pt) 2013-10-01

Family

ID=40548041

Family Applications (1)

Application Number Title Priority Date Filing Date
PT09801447T PT2382198E (pt) 2008-12-23 2009-12-22 Processos e intermediários para a preparação de um inibidor macrocíclico de protease do vhc

Country Status (23)

Country Link
US (2) US8927722B2 (pt)
EP (1) EP2382198B1 (pt)
JP (1) JP5687631B2 (pt)
KR (1) KR101734507B1 (pt)
CN (1) CN102264715B (pt)
AR (1) AR074863A1 (pt)
AU (1) AU2009331530B2 (pt)
BR (1) BRPI0923393B1 (pt)
CA (1) CA2745565C (pt)
CY (1) CY1114488T1 (pt)
DK (1) DK2382198T3 (pt)
ES (1) ES2429013T3 (pt)
HK (1) HK1164839A1 (pt)
HR (1) HRP20130906T1 (pt)
IL (1) IL213246A (pt)
MX (1) MX2011006764A (pt)
PL (1) PL2382198T3 (pt)
PT (1) PT2382198E (pt)
RU (1) RU2016120007A (pt)
SI (1) SI2382198T1 (pt)
SM (1) SMT201300116B (pt)
TW (1) TWI461424B (pt)
WO (1) WO2010072742A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2016120007A (ru) 2008-12-23 2018-11-13 Орто-Макнейл-Янссен Фармасьютикалз, Инк Способы и промежуточные соединения для получения макроциклического ингибитора протеазы вируса гепатита c
BR112014006984A2 (pt) * 2011-09-22 2017-04-04 Janssen Pharmaceuticals Inc processos e intermediários para a preparação de um inibidor macrocíclico de proteases do hcv
CA2848377A1 (en) * 2011-10-28 2013-05-02 Janssen Pharmaceuticals, Inc. Improved process for preparing an intermediate of the macrocyclic protease inhibitor tmc 435
CN103387509B (zh) * 2012-05-11 2016-06-08 重庆博腾制药科技股份有限公司 一种hcv蛋白酶抑制剂中间体的制备方法
BR112014030649A2 (pt) 2012-06-08 2017-06-27 Gilead Sciences Inc inibidores macrocíclicos da flaviviridae vírus
WO2013185103A1 (en) 2012-06-08 2013-12-12 Gilead Sciences, Inc. Macrocyclic inhibitors of flaviviridae viruses
AR091279A1 (es) 2012-06-08 2015-01-21 Gilead Sciences Inc Inhibidores macrociclicos de virus flaviviridae
UA119315C2 (uk) 2012-07-03 2019-06-10 Гіліад Фармассет Елелсі Інгібітори вірусу гепатиту с
WO2014145095A1 (en) 2013-03-15 2014-09-18 Gilead Sciences, Inc. Macrocyclic and bicyclic inhibitors of hepatitis c virus
CN105308043B (zh) * 2014-05-29 2018-01-30 杭州普晒医药科技有限公司 丙型肝炎药物的晶型及其制备方法、其药物组合物和用途
MA41812A (fr) 2015-03-27 2018-01-30 Janssen Pharmaceuticals Inc Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8300536A (nl) * 1983-02-14 1984-09-03 Oce Andeno Bv Optisch actief alfa-azido-p-hydroxyfenylazijnzuur en zijn zouten alsmede de bereiding daarvan.
JPS6124539A (ja) * 1984-07-11 1986-02-03 Sagami Chem Res Center 光学活性(r)−2,5,12−トリヒドロキシ−1,2,3,4−テトラヒドロナフタセン−6,11−ジオン−2−カルボン酸の取得方法
JP4218040B2 (ja) * 1997-12-26 2009-02-04 曽田香料株式会社 有機酸とアミンの複合塩の製造法
JP3844112B2 (ja) 2000-08-23 2006-11-08 高砂香料工業株式会社 3,5,6−トリヒドロキシヘキサン酸アンモニウム塩誘導体、及びその製造方法
NZ548739A (en) 2004-01-30 2010-10-29 Medivir Ab HCV NS-3 Serine protease inhibitors
CN101146794A (zh) 2005-01-21 2008-03-19 阿斯泰克斯治疗有限公司 用于抑制cdk和gsk的吡唑衍生物
PE20070211A1 (es) * 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
MY139988A (en) * 2005-07-29 2009-11-30 Tibotec Pharm Ltd Macrocylic inhibitors of hepatitis c virus
PT2121674E (pt) * 2007-02-01 2010-09-03 Tibotec Pharm Ltd Processos e intermediários para a preparação de um inibidor macrocíclico da protease do hcv
CN101627020B (zh) * 2007-02-08 2015-06-17 泰博特克药品有限公司 抑制hcv的大环苯基氨基甲酸酯
RU2016120007A (ru) 2008-12-23 2018-11-13 Орто-Макнейл-Янссен Фармасьютикалз, Инк Способы и промежуточные соединения для получения макроциклического ингибитора протеазы вируса гепатита c

Also Published As

Publication number Publication date
RU2011130895A (ru) 2013-01-27
US20110257403A1 (en) 2011-10-20
HK1164839A1 (zh) 2012-09-28
BRPI0923393B1 (pt) 2018-06-19
EP2382198B1 (en) 2013-07-10
WO2010072742A1 (en) 2010-07-01
RU2016120007A (ru) 2018-11-13
AR074863A1 (es) 2011-02-16
AU2009331530B2 (en) 2015-04-09
TW201033205A (en) 2010-09-16
DK2382198T3 (da) 2013-09-30
HRP20130906T1 (hr) 2013-10-25
AU2009331530A1 (en) 2011-06-23
IL213246A (en) 2017-10-31
JP5687631B2 (ja) 2015-03-18
KR101734507B1 (ko) 2017-05-11
US8927722B2 (en) 2015-01-06
CN102264715A (zh) 2011-11-30
MX2011006764A (es) 2011-08-03
PL2382198T3 (pl) 2013-11-29
BRPI0923393A2 (pt) 2015-07-28
ES2429013T3 (es) 2013-11-12
SI2382198T1 (sl) 2013-11-29
SMT201300116B (it) 2013-11-08
TWI461424B (zh) 2014-11-21
KR20110099048A (ko) 2011-09-05
CA2745565C (en) 2017-03-07
US20150080577A1 (en) 2015-03-19
CA2745565A1 (en) 2010-07-01
JP2012513381A (ja) 2012-06-14
CY1114488T1 (el) 2016-10-05
CN102264715B (zh) 2015-12-02
US9115077B2 (en) 2015-08-25
EP2382198A1 (en) 2011-11-02
IL213246A0 (en) 2011-07-31

Similar Documents

Publication Publication Date Title
MX2011006764A (es) Procedimiento y compuestos intermedios para preparar un inhibidor de proteasa macrociclico del vhc.
HK1223955A1 (zh) 大環脯氨酸衍生的 絲氨酸蛋白酶抑制劑
WO2011002808A8 (en) Hcv protease inhibitors and uses thereof
MX2011011272A (es) Procesos e intermediarios.
WO2010111436A3 (en) Antiviral compounds and uses thereof
CA2830549C (en) Methods and compositions for preparing noribogaine from voacangine
MY147732A (en) Process for the preparation of 2-substituted-5- (1-alkylthio) alkylpyridines
WO2012082672A3 (en) Process and intermediates for preparing macrolactams
WO2012136383A3 (en) Preparation of sitagliptin intermediates
MY155330A (en) Methods for salt production
AP2008004641A0 (en) Process for preparation of hiv protease inhibitors
MX2012007341A (es) Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
WO2011004402A3 (en) Improved process for the preparation of ambrisentan and novel intermediates thereof
TW200728310A (en) Process for the preparation of ferri-succinylcasein
WO2008021346A3 (en) Pure paliperidone and processes for preparing thereof
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
AU2012248013B2 (en) Intermediate for synthesizing caspofungin and preparation method therefor
WO2010059916A3 (en) Preparation of docetaxel
MX2010001962A (es) Procedimiento para preparar 4-aminobut-2-enolidos.
WO2010027889A3 (en) Process for synthesizing substituted isoquinolines
WO2008111018A3 (en) Process for the preparation of crystals of prulifloxacin
UA34487U (en) Aquananomagnesium
TW200728267A (en) Processes and intermediates for the preparation of prostaglandins
WO2009112149A8 (de) Verfahren zur reinigung therapeutischer proteine mittels mehrstufiger extraktion
MX2009003196A (es) Proceso para la preparacion de y-butirolactonas.